Skip to Main Content

Paper Details

The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus.
Arthritis Res Ther
21
2021
Author NameAffiliation
Babak NoamaniKrembil Research Institute, University Health Network
Paul R FortinCentre de recherche du CHU de Quebec - Universite Laval
Paul R FortinCentre de recherche du CHU de Quebec - Universite Laval
Dafna D GladmanSchroeder Arthritis Institute, University Health Network, University of Toronto
Dafna D GladmanUniversity of Toronto Lupus Clinic, Toronto Western Hospital, University Health Network
Zahi ToumaSchroeder Arthritis Institute, University Health Network, University of Toronto
Zahi ToumaUniversity of Toronto Lupus Clinic, Toronto Western Hospital, University Health Network
Murray B UrowitzSchroeder Arthritis Institute, University Health Network, University of Toronto
Murray B UrowitzUniversity of Toronto Lupus Clinic, Toronto Western Hospital, University Health Network
Joan E WitherSchroeder Arthritis Institute, University Health Network, University of Toronto
Joan E WitherKrembil Research Institute, University Health Network
Joan E WitherUniversity of Toronto
Joan E WitherSchroeder Arthritis Institute, Krembil Research Institute
Joan E WitherSchroeder Arthritis Institute, University Health Network, University of Toronto
Joan E WitherKrembil Research Institute, University Health Network
Joan E WitherUniversity of Toronto
Joan E WitherSchroeder Arthritis Institute, Krembil Research Institute
  • 1 - 17

Datasets